Long-term survival and life expectancy following an acute heart failure hospitalization in Australia and New Zealand.

Aims: Contemporary long-term survival following a heart failure (HF) hospitalization is uncertain. We evaluated survival up to 10 years after a HF hospitalization using national data from Australia and New Zealand, identified predictors of survival, and estimated the attributable loss in life expectancy.

Methods And Results: Patients hospitalized with a primary diagnosis of HF from 2008-2017 were identified and all-cause mortality assessed by linking with Death Registries.

Long term survival after acute myocardial infarction in Australia and New Zealand, 2009-2015: a population cohort study.

Objective: To assess long term survival and patient characteristics associated with survival following acute myocardial infarction (AMI) in Australia and New Zealand.

Design: Cohort study.

Setting, Participants: All patients admitted with AMI (ICD-10-AM codes I21.

Frequency, trends and institutional variation in 30-day all-cause mortality and unplanned readmissions following hospitalisation for heart failure in Australia and New Zealand.

Aims: National 30-day mortality and readmission rates after heart failure (HF) hospitalisations are a focus of US policy intervention and yet have rarely been assessed in other comparable countries. We examined the frequency, trends and institutional variation in 30-day mortality and unplanned readmission rates after HF hospitalisations in Australia and New Zealand.

Methods And Results: We included patients >18 years hospitalised with HF at all public and most private hospitals from 2010-15.

Complications of cardiac implantable electronic device placement in public and private hospitals.

Background: Few safety data exist comparing clinical outcomes in Australian public and private hospitals. We hypothesised that differences could exist between public and private hospitals due to differences in acuity and patient-level co-morbidities.

Aims: To report comparative complications of cardiac implantable electronic device (CIED) placement in public and private hospitals.

Institutional Variation in Quality of Cardiovascular Implantable Electronic Device Implantation: A Cohort Study.

Background: Cardiovascular implantable electronic devices (CIEDs) are associated with procedure-related complications, yet little is known about variation in complication rates among institutions that may suggest disparities in care quality.

Objective: To assess institutional variation in risk-standardized complication rates (RSCRs) for CIED.

Design: Cohort study.

Sex Differences in Acute Complications of Cardiac Implantable Electronic Devices: Implications for Patient Safety.

Background To date, limited population-level studies have examined the impact of sex on the acute complications of cardiac implantable electronic devices ( CIED) , including permanent pacemakers, implantable cardioverter defibrillators, and cardiac resynchronization therapy devices. Methods and Results We studied all patients aged >18 years from 2010 to 2015 who were a resident of Australia or New Zealand, undergoing a new permanent pacemaker, implantable cardioverter defibrillator, or cardiac resynchronization therapy implant. Standardized variables were collected including patient demographic characteristics, primary and secondary diagnoses, procedures performed and discharge status.